## Note
nid: 1521123103327
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Zanki_Step_2, #AK_Step1_v11::#OME_banner::Clinical::13_Gynecology, #AK_Step1_v11::#Physeo::09_Pharm::12_Reproductive::01_Leuprolide,_Goserelin_and_Degarelix, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::2obgyn, #AK_Step2_v11::!Shelf::FM::no_dupes, #AK_Step2_v11::!Shelf::FM::no_dupes::only_step2, #AK_Step2_v11::!Shelf::ObGyn::no_dupes, #AK_Step2_v11::!Shelf::ObGyn::no_dupes::only_step2, #AK_Step2_v11::#B&B::06_ObGyn::Gyne::12_Uterine_Cancer, #AK_Step2_v11::#OME::14_Gynecology::13_Vaginal_Bleeding_3, #AK_Step2_v11::#Resources_by_rotation::FM::ome::gyn::vag_bleed, #AK_Step2_v11::#Resources_by_rotation::ObGyn::ome::gyn::vag_bleed, #AK_Step2_v11::#Resources_by_rotation::ObGyn::uwise::uwise_zanki, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Uterus::Pathology::Leiomyoma_Fibroid, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Uterus::Pathology::Leiomyoma_Fibroid::Management, #AK_Step2_v11::Original_decks::Dorian::fam::ome::gyn::vag_bleed, #AK_Step2_v11::Original_decks::Dorian::obgyn::ome::gyn::vag_bleed, #AK_Step2_v11::Original_decks::Zanki_Step_2::ObGyn::Uwise_&_Step_1
markdown: false

### Text
What <u>medical therapy</u> may be used for <i>short-term</i>
treatment of symptomatic <b>fibroids</b> refractory to OCPs and
NSAIDs?
<div>
  {{c1::GnRH agonists (e.g. leuprolide)}}
</div>

### Extra
<i>not recommended for more than 3 - 6 months; typically used
before a hysterectomy or to bridge a woman close to menopause</i>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/gynecology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_5.png"></a>
</div>

### Additional Resources
<div>
  <div>
    <i>- GnRH agonists desensitize the pituitary via
    <b>overstimulation</b> → diminished release of LH and FSH →
    <b>reduced estrogen</b> synthesis → volume reduction (deprives
    fibroid of its growth stimulus), amenorrhea, improved
    anemia.</i>
  </div>
  <div>
    <i>- They are an optimal treatment <b>prior to surgery</b>,but
    are not suited for long-term monotherapy (> 6 months)
    because they cause rebound growth and bone demineralization
    (osteoporosis). <b>Fibroids continue to grow once therapy is
    discontinued</b>!</i>
  </div>
</div><img src="ez%20(4).png">

### One by one

